Differential sensitivity of MCF-7 and LCC2 cells, to multiple growth inhibitory agents: Possible relation to high bcl-2/bax ratio?

Cancer Letters

Volumn 161, Issue 1, 2000, Pages 27-34

  Lilling, G ^a   Hacohen, H ^a   Nordenberg, J ^b   Livnat, T ^b   Rotter, V ^b   Sidi, Y ^a  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

LCC2 cells; MCF 7 human breast cancer cell line; Sensitivity

Indexed keywords

DOXORUBICIN; FLUOROURACIL; METHOTREXATE; MEVINOLIN; NOVOBIOCIN; PACLITAXEL; PROTEIN BAX; PROTEIN BCL 2; TAMOXIFEN;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER GROWTH; CELL STRAIN MCF 7; CHEMOSENSITIVITY; CONTROLLED STUDY; DRUG RESISTANCE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTINEOPLASTIC AGENTS; BCL-2-ASSOCIATED X PROTEIN; BREAST NEOPLASMS; DRUG RESISTANCE, NEOPLASM; ESTRADIOL; ESTROGEN RECEPTOR MODULATORS; GROWTH INHIBITORS; HUMANS; NEOPLASMS, HORMONE-DEPENDENT; OLIGONUCLEOTIDES, ANTISENSE; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA, MESSENGER; TAMOXIFEN; TUMOR CELLS, CULTURED;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0034624329     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(00)00579-6     Document Type: Article

References (21)

1. c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer
2. MCF-7/LCC2: a 4-hydroxytamoxifen resistant human breast cancer variant that retains sensitivity to the steroidal antiestrogen ICI 182,780
3. Acquisition of hormone-independent growth in MCF-7 cells is accompanied by increased expression of estrogen-regulated genes but without detectable DNA amplifications
4. Hormone resistance, invasiveness, and metastatic potential in breast cancer
5. Inhibition of B16 melanoma cell proliferation and alterations in p21 ras expression by interceptors of signal transduction
6. Measurements of cell death by flow cytometry
7. Tamoxifen-induced apoptosis in breast cancer cells related to down regulation of bcl-2, but not bax and bcl-(x)l, without alteration of p53 protein levels
8. Effect of estrogen on apoptotic pathways in human breast cancer cell line MCF-7
9. Antisense-mediated inhibition of Bcl-2 protooncogene expression and leukemic cell growth and survival: comparisons of phosphodiester and phosphorothioate oligodeoxynucleotides
10. Active cell death induced by the anti-estrogens tamoxifen and ICI 164 384 in human mammary carcinoma cells (MCF-7) in culture: the role of autophagy
11. Apoptotic death in epithelial cells: cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of internucleosomal fragmentation
12. Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis
13. Regulation of apoptosis by bcl-2 family proteins and its role in cancer and chemoresistance
14. Bcl-2 expression is associated with lymph node metastases in human ductal breast carcinoma
15. Bcl-2 but not p53 expression is associated with resistance to chemotherapy in advanced breast cancer
16. Bcl-2 in normal human breast and carcinoma, association with estrogen receptor-positive, epidermal growth factor receptor - negative tumors and in situ cancer
17. Bcl-2 protein expression is associated with prognostically favourable phenotype in breast cancer irrespective of p53 immunostaining
18. Reduced expression of pro-apoptotic gene BAX is associated with poor response rates to combination chemotherapy and shorter survival in women with metastatic breast adenocarcinoma
19. Estrogen promotes chemotherapeutic drug resistance by a mechanism involving Bcl-2 proto-oncogene expression in human breast cancer cells
20. Effects of Bcl-2 antisense oligodeoxynucleotides on in vitro proliferation and survival of normal bone marrow progenitors and leukemic cells
21. Bcl-2 antisense therapy chemosensitizes human melanoma in SCID mice